Intervention News

Hemorrhagic MI is associated with poor outcomes after PCI for STEMI and can be diagnosed via troponin kinetics, not necessarily requiring cardiac MRI, researchers reported at Cardiovascular Research Technologies.

Confirming previously presented earlier results, a paclitaxel-coated balloon was superior to conventional balloon angioplasty for treatment of coronary in-stent restenosis.

Silk Road Medical announced that it has launched the next iteration of its transcarotid stent system in the U.S.

An autologous cell therapy was safe for patients with heart failure with reduced ejection fraction and showed a signal of benefit for patients with elevated baseline N-terminal pro-B-type natriuretic peptide, researchers reported.

Editor’s Note: This is part 2 of a two-part Healio Exclusive series on renal denervation for hypertension control. Part 1 can be viewed here .

Among patients with stable chest pain referred for invasive coronary angiography, a low coronary artery calcium score was associated with low risk for heart attack and stroke, researchers reported in Radiology.

Editor’s Note: This is part 1 of a two-part Healio Exclusive series on renal denervation for hypertension control.

Despite larger declines in STEMI and non-STEMI events from 2011 to 2018, women received proportionately fewer revascularization procedures and had a higher STEMI mortality rate vs. men, researchers reported.

Boston Scientific announced the FDA approval of its drug-coated balloon indicated for the treatment of coronary in-stent restenosis in patients with coronary artery disease.

An HHS panel recommended this week that people with HIV begin taking a statin as young as age 40 years to lower their risk for a serious cardiac event, even if their risk for heart disease is in the low-to-moderate range.